Purpose Distinguishing between complicated and uncomplicated Staphylococcus aureus
bacteraemia (SAB) is therapeutically essential. However, this distinction has limitations in …

The current duration of therapy in patients with Staphylococcus aureus bacteremia (SAB) is
based on differentiating complicated from uncomplicated disease. While this approach …

Objective A cornerstone in the management of Staphylococcus aureus bacteraemia (SAB) is
the differentiation between a complicated and an uncomplicated SAB course. The ability to …

To develop and validate prediction rules to identify the risk of methicillin-resistant
Staphylococcus aureus (MRSA) infection among community patients who have healthcare …

Adjustment for confounding is important in observational methicillin-resistant
Staphylococcus aureus bacteremia (MRSAB) studies due to the wide spectrum of disease …

Objective To estimate the risk of death from healthcare‐associated (nosocomial)
bacteraemia caused by methicillin‐resistant Staphylococcus aureus (MRSA), and compare it …

Staphylococcus aureus bacteremia (SAB) is a severe infection frequently associated with
significant morbidity and mortality. Recent studies have shown that SAB mortality has …

Invasive infections with methicillin-resistant Staphylococcus aureus (MRSA) have been
associated with increased morbidity and mortality. The aim of the present study was to …

Background Stratification to categorize patients with Staphylococcus aureus bacteremia
(SAB) as low or high risk for metastatic infection may direct diagnostic evaluation and enable …

Objectives A high proportion of patients with methicillin-resistant Staphylococcus aureus
(MRSA) bacteraemia die within a few days of the onset of infection. However, predictive …